Hereditary Spastic Paraplegia:Advances in Genetic Research
Neurol 46:1507-1514, Fink,J.K.,et al, 1996

Adult-Onset MELAS
Stroke 27:1420-1423, Gilchrist,J.M.,et al, 1996

Inclusion Body Myositis
JNNP 60:251-255, Garlepp,M.J.&Mastaglia,F.L., 1996

Diagnosis of McArdle's Disease by Molecular Genetic Analysis of Blood
Neurol 47:579-580, El-Schahawi,M.,et al, 1996

Congenital Muscular Dystrophy:Clinical & Pathologic Study of 50 Pts with Classical (Occidental) Merosin-Positive Form
Neurol 46:815-818, Kobayashi,O.,et al, 1996

Congenital Muscular Dystrophy Syndromes Distinguished by Alkaline and Acid Phosphatase, Merosin, & Dystrophin Staining
Neurol 46:810-814, Connolly,A.M.,et al, 1996

Mushroom Myopathy
Muscle & Nerve 19:790-792996., Gonzalez,J.,et al, 1996

Isolated Neck Extensor Myopathy:A Common Cause of Dropped Head Syndrome
Neurol 46:917-921, Katz,J.S.,et al, 1996

Investigation of Muscle Disease
JNNP 60:256-274, Mastaglia,F.L.&Laing,N.G., 1996

AAEM Case Report#13:Diabetic Amyotrophy
Muscle & Nerve 19:939-945996., Chokroverty,S.&Sander,H.W., 1996

Leigh Syndrome:Clinical Features and Biochemical DNA Abnormalities
Ann Neurol 39:343-351, Rahman,S.,et al, 1996

Niemann-Pick Disease Type C from Bench to Bedside
JAMA 276:561-564, Schiffmann,R., 1996

Distal WEakness in Dystrophin-Deficient Muscular Dystrophy
Muscle & Nerve 19:1608-1610996., Felice,K.J., 1996

Practice Parameter:Genetic Testing Alert
Pract Comm Genet Testing Task Force AAN, Neurol 47:1343-13441996., , 1996

Genetic Factors in Alzheimer's Disease:A Review of Recent Advances
Ann Neurol 40:829-840, Levy-Lahad,E.&Bird,T.D., 1996

Clozapine-Induced Myotoxicity in Patients with Chronic Psychotic Disorders
Neurol 47:1518-1523, Scelsa,S.N.,et al, 1996

Inclusion Body Myositis:Clinical and Pathological Boundaries
Ann Neurol 40:581-586, Amato,A.A.,et al, 1996

Congenital Muscular Dystrophy with Primary Laminin a2 (Merosin) Deficiency Presenting as Inflammatory Myopathy
Ann Neurol 40:782-791, Pegoraro,E.,et al, 1996

Charcot-Marie-Tooth Disease and Related Inherited Neuropathies
Medicine 75:233-250, Murakami,T.,et al, 1996

Management Protocol for an Enhancing Cerebral Lesion in HIV Infection
Conn Medicine 60:649-651, Finelli,P.F., 1996

Erroneous Diagnosis Corrected After 28 Years
Arch Neurol 53:1194-1196, Gordon,P.H.,et al, 1996

Confirmation of Linkage of Oculopharyngeal Muscular Dystrophy to Chromosome 14q11. 2-q13
Ann Neurol 40:801-804, Stajich,J.M.,et al, 1996

Atrophy of Bilateral Extraocular Muscles
J Neuro-Ophthalmol 16:286-288, Okamoto,K.,et al, 1996

Presymptomatic Diagnosis of Neurofibromatosis 2 Using Linked Genetic Markers, Neuroimging, and Ocular Examinations
Neurol 47:1269-1277, Baser,M.E., 1996

Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996

Bent Spine Syndrome
JNNP 60:51-54, Serratrice,G.,et al, 1996

Acute Rectus Muscle Palsy in Children as a Result of Orbital Myositis
J Pediatr 128:230-233, Pollard,F.,et al, 1996

Peripheral Neuropathy Secondary to Docetaxel (Taxotere)
Neurol 46:108-111, 21996., New,P.Z.,et al, 1996

Clinical Heterogeneity of Adhalin Deficiency
Ann Neurol 39:196-202, Morandi,L.,et al, 1996

Diagnosis of Merosin (Laminin-2) Deficient Congenital Muscular Dystrophy by Skin Biopsy
Lancet 347:582-584, Sewry,C.A.,et al, 1996

Detection of Nontraumatic Comatose Pts with No Benefit of Intensive Care Trtm by Recording of Sensory Evoked Potentials
Arch Neurol 53:512-516, Madl,C.,et al, 1996

Implementation of an Acute Stroke Program Decreases Hospitalization Costs and Length of Stay
Stroke 27:1040-1043, Wentworth,D.A.&Atkinson,R.P., 1996

Variability in Length of Hospitalization for Stroke:The Role of Managed Care in an Elderly Population
Arch Neurol 53:875-880, Monane,M.,et al, 1996

Results of a Computerized Screening of Stroke Patients for Unjustified Hospital Stay
Stroke 27:639-644, Goldman,R.S.,et al, 1996

Apolipoprotein E Genotyping in Alzheimer's Disease
Lancet 347:1091-1095, Tanzi,R.,et al, 1996

Evidence-Based Medicine, Critical Pathways, Practice Guidelines, & Managed Care:Prevention & Care of Stroke
Arch Neurol 53:867-871, Ringel,S.P.&Hughes,R.L., 1996

Intravenous Immunoglobulin Treatment of Neurological Disease
JNNP 60:359-361, Otten,A.,et al, 1996

The"Gulf War Syndrome"-Is There Evidence of Dysfunction in the Nervous System
JNNP 60:449-451, Jamal,G.A.,et al, 1996

Pure Motor Hand Weakness
Semin Neurol 16:75-81, Lewis,R.A., 1996

Chronic Post-Traumatic Headache Often a Myth
Neurol 46:915-916, Warner,J.S.&Fenichel,G.M., 1996

Sustained Myoglobinuria:The Presenting Manifestation of Dermatomyositis
Neurol 47:119-123, Rose,M.R.,et al, 1996

Multiple Mitochondrial DNA Deletions in Sporadic Inclusion Body Myositis:A Study of 56 Patients
Ann Neurol 39:789-795, Santorelli,F.M.,et al, 1996

Is Chronic Respiratory Failure in Neuromuscular Diseases Worth Treating
JNNP 61:1-3, Shneerson,J.M., 1996

Anticonvulsant Hypersensitivity Syndrome
Arch Int Med 155:2285-2290, Vittorio,C.C.&Muglia,J.J., 1995

The Role of Polyneuropathy in Motor Convalescence After Prolonged Mechanical Ventilation
JAMA 274:1221-1225, Leijten,F.S.,et al, 1995

Evidence for Cardioembolic Stroke in a Case of Kearns-Sayre Syndrome
Stroke 26:1950-1952, Kosinski,C.,et al, 1995

Inclusion Body Myositis and Myopathies
Ann Neurol 38:705-713, Griggs,R.C.,et al, 1995

Myasthenic Symptoms in Patients with Mitochondrial Myopathies
Muscle & Nerve 18:1338-1340995., Forestier,N.L.,et al, 1995

Apolipoprotein E E4 in Inclusion Body Myositis
Ann Neurol 38:957-959, Garlepp,M.J.,et al, 1995

Apolipoprotein E Allele E4, Dementia, and Cognitive Decline in a Population Sample
Lancet 346:1387-1390, Henderson,A.S.,et al, 1995